Discover this podcast and so much more

Podcasts are free to enjoy without a subscription. We also offer ebooks, audiobooks, and so much more from just $11.99/month.

011 - Hey Google, tell me about the importance of living Development Reports with Kyriakos Michailaros

UNLIMITED

011 - Hey Google, tell me about the importance of living Development Reports with Kyriakos Michailaros

FromCMC Live - Chemistry, Manufacturing & Controls


UNLIMITED

011 - Hey Google, tell me about the importance of living Development Reports with Kyriakos Michailaros

FromCMC Live - Chemistry, Manufacturing & Controls

ratings:
Length:
42 minutes
Released:
Oct 9, 2020
Format:
Podcast episode

Description

What We Covered00:53 – Kyriakos Michailaros joins the show to share his background and expertise in the subject matter of drug product services 02:59 – Kyriakos shares his thoughts on appropriate timing for a development report, the validation process and the importance of having your development report be a living document 08:53 – Addressing risks and concerns as it pertains to drug development programs and what Kyriakos looks for in a comprehensive development report 14:56 – Kyriakos speaks to the standards he looks for in development programs when determining dosage form and the value of efficient documentation21:49 – The importance Kyriakos places on stability data and proper documentation 30:03 – Kyriakos explains tablet friability, pan coating, the Ishikawa fishbone diagram and elaborates on the strangest dosage form he’s ever come across40:02 – Ed, Brian and Meranda thank Kyriakos for joining the show Tweetable Quotes“I think it’s never too early. Ideally you want to have the story of the development program pretty much summarized by the time you’re making an NDA submission.”“A good development program is gonna do risk assessments at certain points along the way and assess what are the major concerns associated with developing this drug product.” “Particles tend to de-mix and segregate based on size.”“Some reviewers, it seems, can be primarily box checking, take less of a holistic risk based approach, which has been the trend for some time now. I try to focus on what is actually important for this particular product and has that been explored appropriately.” “If you’re not gonna have a working development report, what you need to have is a working document repository with a file structure that can be easily followed so that you can go back and know what you have and piece together a report or a submission from that.” Relevant LinksDesign Space InPharmatics - LinkedInDesign Space InPharmatics - TwitterKyriakos Michailaros on LinkedInLink to Hey Google, Tell Me About the Importance of Living Development Reports
Released:
Oct 9, 2020
Format:
Podcast episode

Titles in the series (27)

FDA CMC regulations and guidance simplified through examination, real life experiences and risk-based advice. This podcast hopes to educate sponsors and individuals on agency related regulatory CMC matters. We will focus on the critical CMC issues and build programs that enhance drug development. CMC topics will include Regulatory Starting Materials, API and Drug Product Process, Formulation Development, Supply Chains, Analytical Controls. Advocating and interpreting CMC Strategy, directing CMC Operations and Quality Assurance oversight in conjunction with developing CMC submission content that represents the best interests of emerging biotech. NOT INTENDED TO BE PRESCRIPTIVE ADVICE BUT RATHER INTERPRETATION THAT IS RIGHT FOR YOU. Since 2007 we have provided our partners with innovative strategies and exceptional advice intended to enhance program development, product approval, and marketing presence.